FDA Drug Recalls

Recalls / Class III

Class IIID-0991-2019

Product

Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0190-61.

Affected lot / code info
Lot # AA3280A, Exp SEP 2019

Why it was recalled

Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.

Recalling firm

Firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
900 Ridgebury Rd, N/A, Ridgefield, Connecticut 06877-1058

Distribution

Quantity
112 folding cartons
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2019-03-07
FDA classified
2019-03-11
Posted by FDA
2019-03-20
Terminated
2019-09-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0991-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.